BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3982560)

  • 1. DNCB and PPD skin tests and prognosis in 152 patients with breast cancer. A prospective 2-year follow-up.
    Munzarová M; Kovarík J; Hlávková J; Popelínský L; Lauerová L
    Neoplasma; 1985; 32(1):45-50. PubMed ID: 3982560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNCB and PPD skin testing in breast cancer.
    Munzarová M; Kovarík J; Ninger E; Zemanová D; Lauerová L; Kolcová V; Hlávková J; Pacovský Z
    Neoplasma; 1983; 30(4):385-9. PubMed ID: 6888607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The DNCB skin test and its comparison with the radioimmunological determination of CEA in some types of neoplasms].
    Bianucci P; Pastorino G; De Rossi O
    Minerva Med; 1979 May; 70(25):1795-801. PubMed ID: 572515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential evaluation of DNCB reactivity in patients with primary lung cancer. Correlation with prognosis.
    Inoue H; Ishihara T; Kobayashi K; Fukai S
    J Thorac Cardiovasc Surg; 1978 Oct; 76(4):479-82. PubMed ID: 703354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of skin testing with dinitrochlorobenzene in patients with head and neck cancer.
    Osoba D; Kersey PA; Clark RM; Rosen IB
    Can J Surg; 1980 Jan; 23(1):43-4. PubMed ID: 7363157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precipitation of type-I (upgrading) reaction in leprosy by skin testing with antigen and irritants.
    Malhotra B; Das KD; Tutakne MA; Aggarwal SK
    Lepr India; 1983 Apr; 55(2):305-9. PubMed ID: 6632784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The prognostic significance of the immune status (DNCB-test) in patients with carcinoma of the bladder, checked by observation of the course of disease (author's transl)].
    Flamm J; Burkert S
    Wien Med Wochenschr; 1981; 131(13-14):339-43. PubMed ID: 7281701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the dinitrochlorobenzene (DNCB) sensitization test.
    Niwa Y; Niwa H; Kohmura J; Ou DW; Yokoyama MM
    Ann Allergy; 1982 Feb; 48(2):108-12. PubMed ID: 7199878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative DNCB epicutaneous sensitization in leprosy patients and controls.
    Sivamani S; Garg BR; Lal S
    Lepr India; 1981 Jan; 53(1):45-51. PubMed ID: 7218763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tests of cell mediated immunity in patients with early breast cancer. I. Response to DNCB at time of mastectomy.
    Davies CJ; Meredith ID; Robins RA; Blamey RW; Baldwin RW
    Clin Oncol; 1978 Sep; 4(3):227-34. PubMed ID: 750125
    [No Abstract]   [Full Text] [Related]  

  • 11. Dinitrochlorobenzene contact sensitization in pulmonary tuberculosis.
    Malaviya AN; Sehgal KL; Kumar R; Dingley HB
    Clin Exp Immunol; 1975 Dec; 22(3):399-403. PubMed ID: 1225485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "DNCB reactivity in cancer patients and during follow-up period".
    Hardas UD; Jalgaonkar SV
    Indian J Cancer; 1982; 19(5):260-2. PubMed ID: 7166344
    [No Abstract]   [Full Text] [Related]  

  • 13. [Quantitative DNCB reaction in patients with hypernephroma].
    Kreutz G; Bandhauer K
    Z Urol Nephrol; 1980 Feb; 73(2):73-8. PubMed ID: 7445781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The possible evaluation of immunity with the DNCB skin test in relation to blast transformation of lymphocytes].
    Bianucci P; Pastorino G; Brondi P
    Minerva Med; 1982 Oct; 73(41):2891-5. PubMed ID: 7133502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of immune skin reactions in progressive lung cancer during the administration of OK-432--relation to reactions to DNCB, PPD and Su-PS].
    Katada H; Nishikawa K; Yoneda T; Kitamura H; Nakajima A; Mikami R
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):61-70. PubMed ID: 3026256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of skin reactivity in patients with bronchogenic carcinoma grouped according to the TNM classification.
    Plesnicar S; Rudolf Z; Lavrencic D
    Neoplasma; 1977; 24(6):633-40. PubMed ID: 593468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Skin tests as immunologic parameters in cervical cancer].
    Wagner G
    Wien Klin Wochenschr; 1984 Jun; 96(12):467-73. PubMed ID: 6475075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin reactivity to dinitrochlorobenzene in cancer patients.
    Jassem J; Serkies K
    Neoplasma; 1980; 27(5):589-93. PubMed ID: 7231615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The epicutaneous DNCB test and CEA determination in neoplasms of the breast, digestive tract, lung and urogenital system].
    Bianucci P; Pastorino G; De Rossi O; Brondi P
    Minerva Med; 1979 Dec; 70(54):3701-4. PubMed ID: 574929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diminished contact sensitivity response in vitiliginous skin.
    Uehara M; Miyauchi H; Tanaka S
    Arch Dermatol; 1984 Feb; 120(2):195-8. PubMed ID: 6696471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.